Zobrazeno 1 - 2
of 2
pro vyhledávání: '"sars cov-2 main protease inhibitors"'
Autor:
EBENEZER OLUWAKEMI, SHAPI MICHAEL
Publikováno v:
Acta Pharmaceutica, Vol 72, Iss 2, Pp 159-169 (2022)
Some compounds reported as active against SARS CoV were selected, and docking studies were performed using the main protease of SARS CoV-2 as the receptor. The docked complex analysis shows that the ligands selectively bind with the target residues a
Externí odkaz:
https://doaj.org/article/3f13bebf687c495a8c48433213fa1fa1
Autor:
Ebenezer, Oluwakemi, Shapi, Michael
Publikováno v:
Acta Pharmaceutica
Volume 72
Issue 2
Acta Pharmaceutica, Vol 72, Iss 2, Pp 159-169 (2022)
Volume 72
Issue 2
Acta Pharmaceutica, Vol 72, Iss 2, Pp 159-169 (2022)
Some compounds reported as active against SARS CoV were selected, and docking studies were performed using the main protease of SARS CoV-2 as the receptor. The docked complex analysis shows that the ligands selectively bind with the target residues a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0533cc8003d1d962c25c9c074a1363d
https://doi.org/10.2478/acph-2022-0020
https://doi.org/10.2478/acph-2022-0020